| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.67B | 1.68B | 1.87B | 2.02B | 2.08B | 1.94B |
| Gross Profit | 1.17B | 1.19B | 1.29B | 1.33B | 1.38B | 1.32B |
| EBITDA | 338.68M | 343.63M | 53.28M | 293.60M | 445.63M | 395.88M |
| Net Income | 154.36M | 84.16M | -200.32M | 17.23M | 148.31M | 148.26M |
Balance Sheet | ||||||
| Total Assets | 2.56B | 2.69B | 2.73B | 3.11B | 3.36B | 3.45B |
| Cash, Cash Equivalents and Short-Term Investments | 95.11M | 85.88M | 83.40M | 106.71M | 100.40M | 93.80M |
| Total Debt | 897.39M | 899.20M | 887.28M | 883.50M | 940.14M | 989.86M |
| Total Liabilities | 1.81B | 1.94B | 1.99B | 2.06B | 2.22B | 2.36B |
| Stockholders Equity | 2.56B | 752.21M | 739.72M | 1.05B | 1.14B | 1.09B |
Cash Flow | ||||||
| Free Cash Flow | 190.44M | 141.12M | 105.88M | 170.38M | 217.40M | 226.71M |
| Operating Cash Flow | 253.65M | 202.59M | 207.64M | 277.07M | 339.10M | 359.92M |
| Investing Cash Flow | 21.28M | -94.02M | -106.64M | -98.40M | -194.02M | -433.15M |
| Financing Cash Flow | -289.38M | -125.33M | -107.22M | -168.57M | -131.64M | -47.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $13.21B | 32.93 | 17.34% | 0.95% | 8.43% | 21.38% | |
71 Outperform | $1.44B | 13.22 | 20.02% | ― | 5.35% | 33.74% | |
70 Outperform | $1.82B | 13.74 | 13.61% | 4.48% | -5.33% | ― | |
65 Neutral | $902.16M | 3.37 | -0.35% | 2.78% | 2.53% | -23.86% | |
64 Neutral | $8.19B | 20.71 | 8.86% | 2.11% | 1.93% | 34.40% | |
63 Neutral | $1.64B | 30.42 | 2.66% | ― | 5.70% | 97.88% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |
On March 5, 2026, Wiley reported third quarter fiscal 2026 results showing GAAP revenue up 1% to $410 million, operating income up 21% to $63 million, and diluted EPS improving to $0.56 from a loss a year earlier. Adjusted results at constant currency were stronger, with operating income up 22%, EBITDA up 12%, and EPS up 19%, driven by margin expansion, AI momentum, and cost controls.
Research Publishing revenue rose 3% as reported, or 4% at constant currency excluding a tough comparison from a prior AI agreement, supported by strong article submissions and growth in open access and multi-year institutional licenses. Learning revenue dipped 1% amid softness in professional markets, but margins improved slightly thanks to restructuring savings and favorable mix.
AI and data services generated $7 million in quarterly revenue and about $42 million year-to-date, as Wiley expanded partnerships in life sciences, named a new AI and Data Services leader, and after quarter end signed a strategic recurring revenue agreement with OpenEvidence for clinical decision support. The company highlighted surpassing $100 million in lifetime AI revenue and securing its first large language model customer outside the U.S., underscoring AI as an emerging growth pillar.
Corporate expenses fell 21% on an adjusted EBITDA basis, reflecting multi-year efficiency and technology initiatives that contributed to a 280-basis-point improvement in adjusted operating margin. Year-to-date operating cash flow climbed to $103 million and free cash flow to $56 million, while net debt-to-EBITDA eased to 1.7, supporting stronger balance sheet flexibility.
Wiley sharply increased capital returns, deploying $54 million in the quarter and $126 million year-to-date on share repurchases and dividends, and repurchasing nearly 2 million shares so far in fiscal 2026. Management reaffirmed its fiscal 2026 revenue and free cash flow outlook and now expects adjusted EBITDA margin and adjusted EPS to come in at the high end of prior guidance, signaling confidence in ongoing research and AI-driven growth and sustained margin gains.
The most recent analyst rating on (WLY) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on John Wiley Sons Cl A stock, see the WLY Stock Forecast page.
On December 10, 2025, John Wiley & Sons announced an increase in its Fiscal 2026 share repurchase allocation to $100 million, reflecting confidence in its growth trajectory and financial strength. The company reported strong Q2 results, including a 250 basis point improvement in adjusted operating margin and significant growth in research and AI content licensing, while reaffirming its full-year financial guidance.
The most recent analyst rating on (WLY) stock is a Hold with a $34.00 price target. To see the full list of analyst forecasts on John Wiley Sons Cl A stock, see the WLY Stock Forecast page.